Phathom Pharmaceuticals, Inc. (PHAT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US71722W1071
Phathom Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 175.11 m USD |
| Gross profit | 152.51 m USD |
| Operating income | -159.99 m USD |
| EBIT | -160.18 m USD |
| Net income | -221.25 m USD |
| Diluted EPS – continuing operations | -3.03 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
More stocks
- Shenzhen Genvict Technologies Co Ltd (002869.SZ)
- Qualipoly Chemical Corp (4722.TW)
- Jiangsu Hengshang Energy Conservation Technology Co. Ltd. A (603137.SS)
- Suncha Technology Co Ltd (001211.SZ)
- Starling Oncology, Inc. (STLN)
- Shenzhen Chuangyitong Technology Co.Ltd. (300991.SZ)
- Baotou Dongbao Bio-Tech Co Ltd (300239.SZ)
- Great Taipei Gas Corp (9908.TW)
- Unizyx Holding Corp (3704.TW)
- Aquestive Therapeutics, Inc. (AQST)
- FOSTER L B CO (FSTR)
- Impulse Qingdao Health Tech Co Ltd (002899.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.